JASMYN BAIR: Open Payments
NPI 1568114783 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 19 payments from 8 companies in 2025. Trend: 2023 $164 · 2024 $1,191 · 2025 $1,868
Food & beverage: $1,686Education: $182
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $877 |
| GENZYME CORPORATION | 3 | $363 |
| AstraZeneca Pharmaceuticals LP | 2 | $222 |
| E.R. Squibb & Sons, L.L.C. | 2 | $148 |
| Neurocrine BioSciences, Inc. | 1 | $98 |
| Axsome Therapeutics, Inc. | 1 | $74 |
| Stemline Therapeutics Inc. | 1 | $69 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: RYBREVANT, WAYRILZ, TECVAYLI, DARZALEX, OPDIVO, CABLIVI, IMFINZI, DATROWAY.
Industry payments across IN — which companies pay providers there.
